drugset / Trial / NCT02712944

Testosterone Replacement in Renal Failure

NCT02712944 ↗

Phase 1 Terminated 21 enrolled Texas Tech University Health Sciences Center
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this trial is to evaluate the effect of testosterone replacement in men with renal failure (on dialysis) who also have low testosterone. Specifically, the investigators will assess the change in requirement of Erythropoietin Stimulating agents.

Timeline

Start
2016-07
Primary completion
2018-03
Completion
2018-03

Outcome

Outcome not reported

Stopped: “Study stopped for procedural difficulties and lack of personnel”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Testosterone Small molecule — Intramuscular

Indications